CURI · trading date Oct 12, 2026 · previous close $2.81 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$71.66M
Net income
-$6.43M
Total assets
$75.73M
Total liabilities
$34.24M
Stockholders' equity
$41.49M
Cash & equivalents
$18.32M
Operating income
-$7.30M
Operating cash flow
$13.06M
Capital expenditures
$102.0K
Fiscal year 2025, via 10-K filed 2026-03-12.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-10.2%
Net margin
-9.0%
Free cash flow
$12.96M
Free cash flow margin
18.1%
Liabilities / assets
45.2%
Equity / assets
54.8%
CapEx / revenue
0.1%
Operating cash flow / net income
-2.03×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Silver Spring, MD 20910
8484 GEORGIA AVE.
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.